Miragen Therapeutics, Inc. (MGEN): Price and Financial Metrics

Miragen Therapeutics, Inc. (MGEN): $23.01

0.02 (-0.09%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add MGEN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#NR of 481

in industry

MGEN Price/Volume Stats

Current price $23.01 52-week high $34.05
Prev. close $23.03 52-week low $4.66
Day low $22.97 Volume 44,300
Day high $23.90 Avg. volume 134,027
50-day MA $18.20 Dividend yield N/A
200-day MA $14.23 Market Cap 89.92M

MGEN Stock Price Chart Interactive Chart >


Miragen Therapeutics, Inc. (MGEN) Company Bio


Miragen Therapeutics, Inc., a clinical stage biopharmaceutical company, develops microRNA-targeted therapies for various unmet medical needs. It focuses on various therapeutic areas, such as cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. The company was founded in 2006 and is based in Boulder, Colorado.


MGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

MGEN Latest Social Stream


Loading social stream, please wait...

View Full MGEN Social Stream

MGEN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching MGEN

Want to see what other sources are saying about Miragen Therapeutics Inc's financials and stock price? Try the links below:

Miragen Therapeutics Inc (MGEN) Stock Price | Nasdaq
Miragen Therapeutics Inc (MGEN) Stock Quote, History and News - Yahoo Finance
Miragen Therapeutics Inc (MGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!